Welcome to LookChem.com Sign In|Join Free
  • or
2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-dimethylethoxy)carbonyl]amino]-D-threo-hexonic Acid is a complex organic compound characterized by its unique molecular structure. It is a derivative of D-threo-hexonic Acid, featuring an anhydro ring at the 2,6-positions, three deoxygenated carbons at the 3,4,5-positions, and an amino group attached to the 5-position through a (1,1-dimethylethoxy)carbonyl linkage. 2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-threo-hexonic Acid holds potential for various applications in the pharmaceutical and chemical industries due to its distinct structural features and reactivity.

603130-25-2

Post Buying Request

603130-25-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

603130-25-2 Usage

Uses

Used in Pharmaceutical Industry:
2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-dimethylethoxy)carbonyl]amino]-D-threo-hexonic Acid is used as a key intermediate in the synthesis of tetrahydropyran-based dipeptide isoteres. These compounds have shown potential as topoisomerase inhibitors, which are crucial in the development of novel therapeutic agents for various diseases, including cancer.
In the synthesis of tetrahydropyran-based dipeptide isoteres, 2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-threo-hexonic Acid serves as a valuable building block due to its unique structural features. The presence of the anhydro ring and the deoxygenated carbons at specific positions allows for the formation of complex molecular architectures that can interact with biological targets, such as topoisomerases, in a highly specific manner. This interaction can lead to the inhibition of these enzymes, which play a critical role in DNA replication and transcription, and are often overexpressed in cancer cells.
Furthermore, the (1,1-dimethylethoxy)carbonyl group attached to the amino function provides additional opportunities for chemical modification and functionalization, enabling the development of more potent and selective inhibitors. 2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-threo-hexonic Acid's role in the synthesis of topoisomerase inhibitors highlights its importance in the pharmaceutical industry, where the development of new and effective drugs is of utmost importance.

Check Digit Verification of cas no

The CAS Registry Mumber 603130-25-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,3,1,3 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 603130-25:
(8*6)+(7*0)+(6*3)+(5*1)+(4*3)+(3*0)+(2*2)+(1*5)=92
92 % 10 = 2
So 603130-25-2 is a valid CAS Registry Number.

603130-25-2Relevant academic research and scientific papers

Synthesis of novel tetrahydropyran-based dipeptide isosters by overman rearrangement of 2,3-didehydroglycosides

Kriek, Nicole M. A. J.,Van der Hout, Elise,Kelly, Paskal,Van Meijgaarden, Krista E.,Geluk, Annemieke,Ottenhoff, Tom H. M.,Van der Marel, Gijs A.,Overhand, Mark,Van Boom, Jacques H.,Valentijn, A. Rob P. M.,Overkleeft, Herman S.

, p. 2418 - 2427 (2007/10/03)

Differently functionalized tetrahydropyran-based dipeptide isosters have been efficiently synthesized from 3,4,6-tri-Oacetyl-D-glucal. Analogues of the hsp65 p2-13 epitope of Mycobacterium tuberculosis and Mycobacterium leprae were prepared by replacement of the Ala-Tyr or Glu-Glu moiety in the native dodecapeptide with the prepared dipeptide isosters. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 603130-25-2